Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Deckers Outdoor Corp (DECK) vs BIO-TECHNE Corp (TECH) Price & Performance

Deckers Outdoor CorpTrade
BIO-TECHNE CorpTrade

Price performance (Past 24H)

Key statistics

Deckers Outdoor Corp vs BIO-TECHNE Corp — how do they compare? Deckers Outdoor Corp trades at $106.98 (market cap $14.80B), while BIO-TECHNE Corp trades at $71.23 (market cap $11.10B). The key difference: Deckers Outdoor Corp is the larger of the two by market cap, and BIO-TECHNE Corp pays a 0.45% dividend while Deckers Outdoor Corp pays none. Which is the better fit depends on your goals.

DECKTECH
Market Cap
$14.80B$11.10B
Sector
Consumer CyclicalHealth
52-Week High
$123.91$71.38
52-Week Low
$79.54$43.31
Enterprise Value
$13.27B$11.18B
Dividend Yield
0.45%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Deckers Outdoor Corp

DECK trades at $107.80, up 1.71% for the day, with a bullish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.96 exceeding the $0.83 estimate. Revenue grew to $4.99B in 2025, and net income reached $966M. Analyst consensus price target is $122.44, suggesting potential upside. Recent news highlights robust brand momentum for UGG and HOKA, with international sales growth offsetting domestic stagnation.

Outlook remains positive driven by earnings growth and strong cash flow, but risks include reliance on key brands and competitive pressures. The stock offers a reasonable valuation with a P/E of 15.36 and high profitability metrics, though technical indicators show some overbought conditions near-term.

BIO-TECHNE Corp

Bio-Techne (TECH) trades at $71.36, showing minimal daily movement (+0.08%) as the market digests Merck KGaA's $73 per share acquisition offer. The stock sits just 2.3% below the buyout price, with technical indicators showing bullish momentum. Fundamentally, the company maintains strong gross margins (64.96%) but faces declining net income margins (6.01% in 2025). Recent earnings show mixed results with one beat and two misses in the last four quarters.

The acquisition premium provides near-term upside potential, though shareholder litigation risks exist regarding deal fairness. Long-term investors face uncertainty about post-acquisition prospects, while current valuation metrics (P/E 101.94) appear stretched without the takeover scenario. The $73 offer price represents the primary catalyst, with downside risk to $50 if the deal fails.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Deckers Outdoor Corp

Deckers Outdoor Corp designs and sells casual and performance footwear, apparel, and accessories. Primary brands include UGG, Teva, and Sanuk. The company distributes Most of its products through its wholesale business, but it also has a substantial direct-to-consumer business with its company-owned retail stores and websites. Most sales are in the United States, although the company also has retail stores and distributors throughout Europe, Asia, Canada, and Latin America. Deckers sources its products from independent manufacturers primarily in Asia.

Read more on DECK

About BIO-TECHNE Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.

Read more on TECH